Due to the COVID-19 pandemic, new patient appointments are now conducted through a secure telehealth portal.
CALL US TODAY FOR AN APPOINTMENT
Ketamine and esketamine (Spravato™) for treatment-resistant depression provided by Lott Behavioral Health. Due to the COVID-19 pandemic, our evaluations are now being conducted online, and treatment sessions, if appropriate, are conducted in the office.
Ketamine is an anesthetic medication which is now used for treating depression and other conditions. We provide ketamine infusion services for depression which has not responded to other treatments.
Working through a different mechanism than typical antidepressants, ketamine provides far more rapid results than traditional treatments.
Esketamine (Spravato™) is FDA-approved for treatment-resistant depression. It is chemically related to ketamine, but is given intranasally and must be administered and monitored in an approved clinic.
Esketamine treatments require 2 hours of observation in the clinic following each administration.
An evaluation in the office is required before approval for ketamine or esketamine treatment, including a thorough review of prior treatments for depression.
You will receive an evaluation and treatment plan from Dr. Lott and his team, designed for your specific history and needs.
4300 Commerce Ct., Suite 250
Lisle, IL 60532